Adjunctive therapies are not only vital to the success of cancer treatments, enhancing compliance and outcomes, but they are also a dynamic area of research and development in a variety of disciplines from drug delivery to biologics. It also happens to be the largest portion of the overall cancer therapeutics market.
This report provides the reader with a comprehensive analysis of the worldwide market for therapeutics to treat and manage symptoms in cancer patients. Market information, including market size and growth, is provided for 2003 to 2010 on various product subcategories included in the major segments:
- antinauseants and antiemetics
- pain management
- blood modifiers
- infection control
- other therapies.
In addition, competitive market share and a four-region geographic breakdown are provided for the base year 2005. The study also covers issues and trends affecting the market, research and development pipelines, demographics, cancer statistics, the epidemiology of side effects, and more.